-
TRIM66 and the One-Neuron-One-Receptor Rule
2026-08-25
The reference study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence surplus olfactory receptor genes and achieve monogenic receptor expression. Its loss disrupts receptor selection, neural olfactory processing, and innate odor-guided behavior, linking chromatin regulation to sensory function.
-
TAK1–YAP Control of Gastric Cancer Stem Cells
2026-08-25
The reference study identifies TGFβ-activated kinase 1 (TAK1) as an upstream regulator of YAP stability and gastric cancer stem-cell self-renewal. Its findings connect IL-6 signaling, cytoplasmic YAP preservation, and SOX2/SOX9 transcription, providing a mechanistic framework for studying gastric cancer recurrence, tumorigenesis, and treatment resistance.
-
Thrombin Fragment A1057: Reliable Cell Assays
2026-08-24
This scenario-driven guide shows how Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] (SKU A1057) can improve the interpretability of cell viability, proliferation, and cytotoxicity workflows. It covers identity control, solvent compatibility, preparation, assay interference, data interpretation, and practical vendor selection without overstating evidence for intact thrombin activity.
-
Metformin and Nr4a1/Wnt Signaling in Tendon HO
2026-08-24
A 2026 Experimental Cell Research study identifies an Nr4a1/Wnt/β-catenin mechanism through which metformin suppresses heterotopic ossification in mouse Achilles tendon and tendon-derived stem cells. The work connects a clinically familiar metabolic compound with a defined osteogenic signaling axis, while providing a framework for testing pathway-level interventions in tendon calcification.
-
PD 173074 Dissects FGF-2 Neuronal Signaling
2026-08-23
The 2000 Journal of Neurochemistry study established PD 173074 as a potent and selective pharmacological antagonist of FGF-2-driven neuronal survival, neurite outgrowth, and MAPK signaling. Its comparative use against other trophic factors and SU 5402 showed how receptor-level inhibition can distinguish FGF-2 biology from downstream or unrelated neurotrophic mechanisms.
-
Mouse Tissue Lysis Kit (K1038) Protocol
2026-08-22
The Mouse Tissue Lysis Kit (K1038) prepares mouse tissue lysates for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and assay development, not diagnostic, clinical, or medical testing.
-
5-Methyl-CTP: From IVT Chemistry to Translation
2026-08-21
5-Methyl-CTP can help translational teams connect modified-nucleotide design with the practical demands of mRNA stability, protein expression, and delivery. This article examines the mechanistic rationale, experimental strategy, and translational limits of using 5-methyl modified cytidine triphosphate in mRNA workflows, including its relevance to emerging outer membrane vesicle vaccine platforms.
-
BMS 599626 Dihydrochloride in Senescence Screens
2026-08-21
BMS 599626 dihydrochloride is an EGFR and ErbB2 inhibitor that can serve as a mechanistic perturbation tool in cancer and senescence research. This article explains how to distinguish receptor-driven growth arrest from genuine senolytic activity and integrate the compound into machine-learning-guided assay workflows.
-
Rotigotine hydrochloride in PD Research Workflows
2026-08-20
Rotigotine hydrochloride is a versatile dopamine D2/D3 receptor agonist for connecting cellular neuroprotection studies with route-sensitive Parkinson’s disease models. Its distinctive value is the ability to interrogate motor, inflammatory, and lower urinary tract phenotypes within one dopaminergic research strategy.
-
L-Alanyl-L-Glutamine: From Barrier Biology to Translation
2026-08-20
A translational framework for using L-Alanyl-L-glutamine as a stable, water-soluble dipeptide in intestinal barrier research, while distinguishing mucosal-support evidence from direct antiviral claims.
-
FLCN mRNA Rescue: From Variant to Validation
2026-08-19
A translational framework for converting FLCN variant biology into a reproducible mRNA rescue workflow, with practical guidance on T7 transcription, RNA quality, assay design, and the limits of early cellular evidence.
-
Methyl-β-cyclodextrin: Membrane Workflow Guide
2026-08-19
Methyl-β-cyclodextrin (SKU C6939) provides a practical way to extract cholesterol and selected lipids from cellular membranes when researchers need to study membrane organization, fluidity, or cholesterol-dependent signaling. It is intended for controlled laboratory experiments only, not diagnostic or medical use, and working conditions should be optimized empirically because no directly matched paper evidence is supplied for this product.
-
Cy5 TSA Fluorescence System Kit: Mechanism & Use
2026-08-18
The Cy5 TSA Fluorescence System Kit uses horseradish peroxidase catalyzed tyramide deposition to increase fluorescent detection of low-abundance targets in IHC, ICC, and FISH. Its Cy5 readout is reported at 648 nm excitation and 667 nm emission, with rapid labeling within 10 minutes according to the product information.
-
Flavopiridol Workflows for CDK and ER-Stress Studies
2026-08-18
Flavopiridol, also known as L868275, provides a practical way to connect pan-CDK inhibition with cell-cycle arrest, apoptosis, and transcriptional readouts. This guide translates intestinal endoplasmic-reticulum-stress findings into controlled assay designs for cancer research while clearly separating established evidence from exploratory applications.
-
Targeted SPP1 Inhibition in Tumor Myeloid Cells
2026-08-17
The reference study identifies a phenotypic small-molecule strategy for reducing SPP1 expression in tumor-associated macrophages and integrates lead compounds into a TAM-avid nanodelivery system. Its lead compound, CANDI460, decreased SPP1 in vitro and in vivo and produced tumor remissions in multiple murine models, providing a framework for myeloid-directed cancer therapy.